Abstract
Therapeutic cancer vaccines aim to generate tumor immunity through coordinated cell- and antibody-mediated responses that ultimately result in highly specific and potent T cells capable of destroying cancers. Cancer vaccines have unique advantages compared to most other cancer therapeutics, with a high degree of specificity for tumor cells relative to normal tissues, a highly favorable side-effect profile, and the potential for a long-lasting treatment effect due to immunologic memory.
Original language | English (US) |
---|---|
Title of host publication | Cancer Therapeutic Targets |
Publisher | Springer New York |
Pages | 561-574 |
Number of pages | 14 |
Volume | 1-2 |
ISBN (Electronic) | 9781441907172 |
ISBN (Print) | 9781441907165 |
DOIs | |
State | Published - Jan 1 2017 |
Keywords
- Chemotherapy
- Combination immunotherapy
- Immune response
- Immunotherapy
- Monoclonal antibody
- Whole-cell vaccine
ASJC Scopus subject areas
- General Medicine
- General Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics(all)